Drug Type Small molecule drug |
Synonyms AWD 5239 |
Target |
Mechanism 5-HT2 receptor antagonists(Serotonin 2 (5-HT2) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC28H37N3O11 |
InChIKeyKOOVVKLOLJXSHE-CHTWJNJDSA-N |
CAS Registry146086-86-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Phase 2 | DE | - | |
Cognition Disorders | Phase 2 | - | - | |
Cognition Disorders | Phase 2 | - | - |